Investor Relations September 5, 2024 Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment Read More
Investor Relations, Videos July 29, 2024 Discover Nexalin’s Neurostimulation Device Targeting Mental Health Disorders Read More
Investor Relations July 18, 2024 Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery Read More
Investor Relations, Videos July 29, 2024 Discover Nexalin’s Neurostimulation Device Targeting Mental Health Disorders Read More
Investor Relations, Videos April 18, 2024 Nexalin Technology unveils positive results of clinical study for Gen-2 tACS device Read More